CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 10, 2022 · earnings

ORMP earnings: a positive outcome, +6.0%

On November 10, 2022, ORAMED PHARMACEUTICALS INC. reached its earnings. The result was a positive outcome, and the stock moved +6.0% in the window around the event. It had already run +11.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$6.21
1d before
$6.58
Event day
$7.55
1d after
$9.00
5d after

Pre-catalyst setup

+11.3%
30-day run-up
4886%
30-day volatility
1.1×
volume spike